Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	82.44	143.95	202.83	238.98	393.57	135.99
Cash & Short-Term Investments	82.44	143.95	202.83	238.98	393.57	135.99
Cash Growth	-37.11%	-29.03%	-15.13%	-39.28%	189.41%	45.10%
Accounts Receivable	82.78	70.43	69.76	47.97	54.26	50.66
Other Receivables	3.86	28.83	25	8.21	4.94	2.02
Receivables	86.64	99.26	94.76	56.18	59.2	52.68
Inventory	147.1	114.48	111.48	68.66	81.8	52.71
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	65.46	49.61	40.22	30.48	15.32	16.15
Total Current Assets	381.64	407.3	449.29	394.3	549.89	257.54
Property, Plant & Equipment	562.2	588.4	639.49	584.83	509.63	420.78
Long-Term Investments	79.79	80.18	108.81	170.74	99.98	69.93
Goodwill	58.97	58.97	58.97	58.97	58.97	58.97
Other Intangible Assets	236.04	251.66	292.08	100.83	118.93	92.15
Long-Term Deferred Tax Assets	1.36	1.47	1.15	71.07	43.07	23.9
Long-Term Deferred Charges	35.81	42.78	47.75	55.22	32.56	63.96
Other Long-Term Assets	9.34	8.06	16.94	58.87	33.74	18.55
Total Assets	1,365	1,439	1,614	1,495	1,447	1,006
Accounts Payable	221.86	53.38	49.29	22.27	85.53	79.45
Accrued Expenses	17.28	174.67	175.34	89.05	38.62	37.76
Short-Term Debt	153.02	182.18	219.18	209.27	77.76	129.18
Current Portion of Long-Term Debt	-	117.92	72.12	17.94	62.47	-
Current Portion of Leases	-	0.1	0.18	0.19	0.11	-
Current Income Taxes Payable	-	2.91	1.67	3.8	3.77	3.01
Current Unearned Revenue	5.43	3.57	11.91	8.22	6.63	3.86
Other Current Liabilities	170.34	40.05	68.07	57.8	27.42	40.86
Total Current Liabilities	567.92	574.78	597.76	408.55	302.31	294.12
Long-Term Debt	137.08	142.36	167.69	84.04	47	82
Long-Term Leases	-	-	0.09	0.1	-	-
Long-Term Unearned Revenue	63.92	65.99	39.99	42.33	45.56	45.25
Long-Term Deferred Tax Liabilities	2.5	2.67	2.38	2.42	2.05	2.42
Other Long-Term Liabilities	268.11	256.24	237.31	1.79	-	-
Total Liabilities	1,040	1,042	1,045	539.22	396.92	423.79
Common Stock	159.27	159.27	159.27	159.27	158.78	140
Additional Paid-In Capital	607.17	607.93	607.93	671.32	659.29	176.43
Retained Earnings	-473.7	-407.01	-250.71	97.88	225.28	260.17
Total Common Equity	292.74	360.18	516.48	928.46	1,043	576.6
Minority Interest	32.88	36.6	52.76	27.16	6.49	5.39
Shareholders' Equity	325.62	396.78	569.24	955.62	1,050	581.99
Total Liabilities & Equity	1,365	1,439	1,614	1,495	1,447	1,006
Total Debt	290.1	442.56	459.27	311.55	187.33	211.18
Net Cash (Debt)	-207.66	-298.6	-256.44	-72.57	206.24	-75.19
Net Cash Per Share	-1.30	-1.87	-1.61	-0.46	1.38	-0.54
Filing Date Shares Outstanding	159.3	159.27	159.27	159.27	158.78	140
Total Common Shares Outstanding	159.3	159.27	159.27	159.27	158.78	140
Working Capital	-186.28	-167.48	-148.48	-14.25	247.58	-36.58
Book Value Per Share	1.84	2.26	3.24	5.83	6.57	4.12
Tangible Book Value	-2.28	49.56	165.44	768.66	865.45	425.48
Tangible Book Value Per Share	-0.01	0.31	1.04	4.83	5.45	3.04
Buildings	-	565.95	565.02	536.94	397.03	393.34
Machinery	-	267.27	268.43	179.92	116.23	108.6
Construction In Progress	-	29.76	29.86	50.6	147.22	44.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.